Indian drugmakers may benefit as EU mulls easier access to generics
The European Commission wants to make it easier for patients to access cheaper, generic medicines, a draft EU document seen ......
Eris Lifesciences to buy Strides Shasun's India generics biz for $77 mn
Eris Lifesciences Ltd has agreed to acquire Strides Shasun Ltd’s branded generics business in India for Rs 500 crore ($77 ......
Recommended for you